Effectiveness of MedCem-MTA® versus Formocresol as dressing agents in pulpotomized primary molars: preliminary results.

Objectives: The objective of this prospective randomized clinical trial is to assess, clinically and radiographically, the effect of MedCem-MTA® as a pulp medicament following coronal pulp amputation in human primary molars with carious pulp exposure in comparison to Formocresol.
Methods: Following standard pulpotomy procedure, the pulp stumps of 68 primary molars in 60 healthy children were randomly covered either with MedCem-MTA® or Formocresol. The pulp chambers were filled with Intermediate Restorative Material (IRM®) and teeth were restored with stainless steel crowns. At six months and twelve months follow-up appointments, the clinical status of the treated teeth was assessed and radiographs were taken.
Results: See Table attached
Conclusions: Preliminary results demonstrated a success rate of 100% for MedCem-MTA® while that of Formocresol was 94%, similar to that described in the literature.